Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-EN
Language English English
Date Updated 2024-04-16 2024-04-02
Drug Identification Number 02426870 02426870
Brand name APTIOM APTIOM
Common or Proper name eslicarbazepine acetate tablets eslicarbazepine acetate tablets
Company Name SUMITOMO PHARMA CANADA, INC. SUMITOMO PHARMA CANADA, INC.
Ingredients ESLICARBAZEPINE ACETATE ESLICARBAZEPINE ACETATE
Strength(s) 400MG 400MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code N03AF N03AF
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-04-15 2024-04-05
Actual start date
Estimated end date 2024-04-30 2024-04-27
Actual end date 2024-04-15
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Company anticipates the shortage will be limited from a few days to a few weeks.
Health Canada comments